overall-survival

Documents about overall-survival

• The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer#885879ClinicalTrials.gov
• Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data#914824ClinicalTrials.gov
• A comparison of overall survival from early-onset and late-onset colorectal cancer stratified by TNM stage: a systematic review#372652Springer Nature OA
• TUPKRP Combined With MAB Therapy for LUTS/PCa#803051ClinicalTrials.gov
• Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma#915244ClinicalTrials.gov
• Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium#928588Springer Nature OA
• Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)#969854ClinicalTrials.gov
• Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non-small cell lung cancer and brain metastases receiving whole-brain radiotherapy.#402596NCBI PubMed Central
• Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.#1031396ClinicalTrials.gov
• Measuring the improvement in overall survival among patients with advanced gastroenteropancreatic neuroendocrine tumors over the past two decades#14758DataCite
• Measuring the improvement in overall survival among patients with advanced gastroenteropancreatic neuroendocrine tumors over the past two decades#14759DataCite
• Tumor hypoxia is associated with global copy-number alteration burden and subtype-dependent overall survival in breast cancer: Evidence from TCGA and METABRIC#251492PLOS
• Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM#829773ClinicalTrials.gov
• Prognostic Value Of Chemotherapy-Induced Neutropenia In Metastatic Colorectal Cancer At Rsup Dr Sardjito Yogyakarta#930397Acta Interna: The Journal of Internal Medicine
• Impact of Ultra-fast Genetic Diagnosis of Familial Lymphohistiocytosis on the Time to Bone Marrow Transplantation and Overall Survival#1031385ClinicalTrials.gov
• Response to the letter Re: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting#218364IRIS
• SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)#867658ClinicalTrials.gov
• High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma#980846ClinicalTrials.gov
• Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2− metastatic breast cancer using real-world data in France and Germany#171622HAL (France)
• A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden#866968ClinicalTrials.gov
• Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)#993427ClinicalTrials.gov
• Correction: Malnutrition assessed by the mini nutritional assessment is associated with overall survival in patients with resectable non–small cell lung cancer / Denis I. Trufa, Koblandy Khamitov, Lena Kopplin, Horia Sirbu#675525Deutsche Nationalbibliothek
• Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib#867757ClinicalTrials.gov
• YK-4-250 Mitigates Gastrointestinal Radiation Syndrome and Promotes Overall Survival Following Partial Body Radiation Injury#393078ODU Digital Commons
• Combination of Metformin With Gefitinib to Treat NSCLC#889323ClinicalTrials.gov
• Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort#922929HAL (France)
• First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials#991168Bielefeld Pub
• Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: analysis of 956 patients#955482Koc University Digital Collections
• Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype#887833ClinicalTrials.gov
• Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.#892875ClinicalTrials.gov
• En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria#979720ClinicalTrials.gov
• Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017#338807OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer#883647ClinicalTrials.gov
• Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer#852972ClinicalTrials.gov
• Salvage radiotherapy confers an overall survival advantage in biochemical recurrence of prostate cancer: evidence from the international PROMISE registry / Nika Guberina, Madeleine J. Karpinski, Maja Guberina, Sebastian Hoberück, Matthias Miederer, Tobias Hölscher, Isabel Rauscher, Matthias Eiber, Andrew Nguyen, Lela Theus, Matteo Bauckneht, Helen Scholtissek, Kambiz Rahbar, Jonathan Miksch, Daniele Antonio Pizzuto, Karolien Goffin, Caner Civan, Shima F. Reinwand, Andreas Stang, Jens Kleesiek, Anja Merkel-Jens, Lale Umutlu, Alfonso Santangelo, Timo F. W. Soeterik, Stephan Beintner-Skawran, Andrej Vondrak, Anders Bjartell, Laura Evangelista, Sazan Rasul, Marcin Miszczyk, Adrien Holzgreve, Gabriel T. Sheikh, Andrea Di Giorgio, Andrea Farolfi, Ken Herrmann, Boris Hadaschik, Wolfgang P. Fendler, Martin Stuschke#783931Deutsche Nationalbibliothek
• Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer#837526ClinicalTrials.gov